AVVie

Medical Equipment Manufacturing • Vienna, Vienna, Austria • 11-20 Employees

Company overview

Headquarters	Vienna, Vienna, Austria
Website	angelvalve.com
NAICS	3391
SIC	384
Keywords	Medical Device, Mitral Regurgitation, Mitral Valve
Founded	2018
Employees	11-20
Socials

Key Contacts at AVVie

Werner Mohl

Founder

Khushbu Jariwala

Director- General Administration

Thananya Khienwad

R&D Director

AVVie Email Formats

AVVie uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@angelvalve.com), used 50% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@angelvalve.com	50%
{first name}{last name}	johndoe@angelvalve.com	50%

About AVVie

More than 13 million people in Europe and the US suffer from mitral valve regurgitation (blood leaking back into the heart´s left atrium) but only less then 5% of moderate to severely ill patients get treated. AVVie has developed the Mitral Butterfly (MB) system, a novel innovative solution for patients suffering from MR and subsequent heart failure. Mitral Butterfly is a hemi valve replacing the function of the native, dysfunctioning posterior leaflet. The Mitral Butterfly restores full coaptation with a nitinol-based frame and a pericardial membrane by sliding over the diseased leaflet while preserving the motion and function of the anterior leaflet. The Mitral Butterfly has been designed to prevent unphysiological inflow (regurgitation) caused by diverse pathophysiologic origins like DMR and FMR and to minimize the outflow obstruction (stenosis). The delivery can be done by both minimally invasive surgery and by transseptal delivery.

AVVie revenue & valuation

Annual revenue	$941,105
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$3,100,000
Total funding	$2,400,000